...
首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats.
【24h】

Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats.

机译:阿托伐他汀对大鼠后肢缺血中血管生成和内皮祖细胞形成的影响。

获取原文
获取原文并翻译 | 示例

摘要

AIM: To investigate the mechanisms underlying the pro-angiogenic effects of statin, the effects of atorvastatin were investigated on the expression of angiogenic factors in ischemic hindlimbs of rats. The function and number of endothelial progenitor cells (EPCs) were investigated in hypertensive rats. METHODS: Hindlimb ischemia rats were administered 10 or 30 mg/kg/day atorvastatin orally for 2 weeks. Angiogenesis was evaluated by a laser Doppler and by Isolectin-B4 immunostaining. The expressions of VEGF, IL-8, angiopoietin (Ang)-1, Ang-2, eNOS, and hemoxidase (HO)-1 were evaluated by Western blotting and immunohistochemistry. Spontaneously hypertensive rats (SHR) were administered 10 mg/kg/day atorvastatin. EPC function was evaluated by colony formation and migration. The EPC number was evaluated by CD34-positive cells. RESULTS: A lowdose of atorvastatin, but not a highdose, significantly increased regional blood flow. Atorvastatin significantly increased the expressions of VEGF, IL-8, Ang-1, Ang-2, eNOS, and HO-1 proteins in ischemic hindlimbs. Atorvastatin significantly increased the number and colony formation of EPCs and decreased oxidation in mononuclear cells from SHR. CONCLUSION: Atorvastatin strongly induced angiogenesis with increases in angiogenic cytokines, HO-1 and EPC numbers. Statins are thus considered potertial agents for therapeutic angiogenesis.
机译:目的:探讨他汀类药物促血管生成作用的潜在机制,研究阿托伐他汀对大鼠缺血后肢血管生成因子表达的影响。在高血压大鼠中研究了内皮祖细胞(EPC)的功能和数量。方法:后肢缺血大鼠口服阿托伐他汀10或30 mg / kg /天,持续2周。通过激光多普勒和Isolectin-B4免疫染色评估血管生成。通过Western印迹和免疫组织化学评估VEGF,IL-8,血管生成素(Ang)-1,Ang-2,eNOS和血红素酶(HO)-1的表达。自发性高血压大鼠(SHR)服用10 mg / kg /天的阿托伐他汀。通过菌落形成和迁移来评估EPC功能。 EPC编号由CD34阳性细胞评估。结果:低剂量的阿托伐他汀,而不是大剂量,显着增加了局部血流量。阿托伐他汀显着增加缺血后肢中VEGF,IL-8,Ang-1,Ang-2,eNOS和HO-1蛋白的表达。阿托伐他汀显着增加了SHR产生的单核细胞中EPC的数量和集落形成,并减少了氧化。结论:阿托伐他汀强烈诱导血管生成,血管生成细胞因子,HO-1和EPC数量增加。因此他汀类被认为是用于治疗性血管生成的增效剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号